| Is quality of life in non‐demented Parkinson’s disease patients related to cognitive performance? A clinic‐based cross‐sectional study N Klepac, V Trkulja, M Relja, T Babić European journal of neurology 15 (2), 128-133, 2008 | 196 | 2008 |
| Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects: A cross-sectional study N Klepac, M Relja, R Klepac, S Hećimović, T Babić, V Trkulja Journal of neurology 254, 1676-1683, 2007 | 195 | 2007 |
| Effects of melatonin on plasma oxidative stress in rats with streptozotocin induced diabetes N Klepac, Z Rudeš, R Klepac Biomedicine & pharmacotherapy 60 (1), 32-35, 2006 | 95 | 2006 |
| Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross‐sectional study in Croatia N Klepac, S Pikija, T Kraljić, M Relja, V Trkulja, S Juren, I Pavliček, ... European Journal of Neurology 14 (2), 194-198, 2007 | 62 | 2007 |
| IL-1β, IL-6, IL-10, and TNF α single nucleotide polymorphisms in human influence the susceptibility to Alzheimer’s disease pathology M Babić Leko, M Nikolac Perković, N Klepac, DŠ Štrac, F Borovečki, ... Journal of Alzheimer's Disease 75 (3), 1029-1047, 2020 | 54 | 2020 |
| The effects of electroconvulsive therapy augmentation of antipsychotic treatment on cognitive functions in patients with treatment-resistant schizophrenia BV Cusa, N Klepac, N Jakšic, Z Bradaš, M Božicevic, N Palac, M Šagud The journal of ECT 34 (1), 31-34, 2018 | 39 | 2018 |
| Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia S Kiđemet‐Piskač, M Babić Leko, A Blažeković, L Langer Horvat, ... CNS neuroscience & therapeutics 24 (8), 734-740, 2018 | 37 | 2018 |
| A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease M Relja, N Klepac Journal of the neurological sciences 248 (1-2), 251-254, 2006 | 33 | 2006 |
| Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms N Klepac, S Hajnšek, V Trkulja Journal of geriatric psychiatry and neurology 23 (1), 15-26, 2010 | 31 | 2010 |
| Genetic background of huntington disease in Croatia: molecular analysis of CAG, CCG, and Δ2642 (E2642del) polymorphisms S Hećimović, N Klepac, J Vlašić, A Vojta, D Janko, I Škarpa‐Prpić, ... Human mutation 20 (3), 233-233, 2002 | 27 | 2002 |
| Nondemented Parkinson disease patients: is cognitive performance associated with depressive difficulties? N Klepac, V Trkulja, M Relja Cognitive and behavioral neurology 21 (2), 87-91, 2008 | 25 | 2008 |
| Botulinum toxin type A as prophylactic treatment in chronic tension type headache: long-term follow-up study MA Relja, N Klepac Neurology 56 (8), A349-A350, 2001 | 25 | 2001 |
| Hrvatska strategija borbe protiv Alzheimerove bolesti i drugih demencija-prijedlog nacrta uz nadopune N Mimica, M Kušan Jukić, P Presečki, M Ivičić, M Braš, L Vrbić, M Boban, ... Medix 21 (117), 111-118, 2015 | 24 | 2015 |
| Association of MAPT haplotype‐tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort M Babić Leko, N Willumsen, M Nikolac Perković, N Klepac, F Borovečki, ... Brain and Behavior 8 (11), e01128, 2018 | 22 | 2018 |
| Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients N Klepac, S Hajnšek, V Trkulja Parkinsonism & related disorders 16 (1), 21-27, 2010 | 22 | 2010 |
| Relationships of cerebrospinal fluid Alzheimer’s disease biomarkers and COMT, DBH, and MAOB single nucleotide polymorphisms M Babić Leko, M Nikolac Perković, N Klepac, D Švob Štrac, F Borovečki, ... Journal of Alzheimer's Disease 73 (1), 135-145, 2020 | 21 | 2020 |
| Comparison of two commercial enzyme-linked immunosorbent assays for cerebrospinal fluid measurement of amyloid β1–42 and total tau M Babić, Ž Vogrinc, A Diana, N Klepac, F Borovečki, P Hof, G Šimić Translational neuroscience 4 (2), 234-240, 2013 | 17 | 2013 |
| Education effect on depression and quality of life in nondemented Parkinson’s disease patients N Klepac, V Trkulja The Journal of neuropsychiatry and clinical neurosciences 21 (3), 314-322, 2009 | 15 | 2009 |
| An update on the management of young-onset Parkinson’s disease N Klepac, M Habek, I Adamec, AK Barušić, I Bach, E Margetić, I Lušić Degenerative neurological and neuromuscular disease, 53-62, 2013 | 14 | 2013 |
| Unraveling the biological mechanisms in Alzheimer's disease—Lessons from genomics F Borovecki, N Klepac, D Muck-Seler, S Hajnsek, Z Mubrin, N Pivac Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (2), 340-347, 2011 | 14 | 2011 |
